Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy
Clinical Re-evaluation of Removing Blood Stasis Therapy of Herbal Medicine in Treating Acute Cerebral Hemorrhage Safety
Sponsor: Guangzhou University of Traditional Chinese Medicine
This PHASE4 trial investigates Intracerebral Hemorrhage and is currently ongoing. Guangzhou University of Traditional Chinese Medicine leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status PHASE4
Status: Enrolling By Invitation → Unknown Status
-
Jan 2017 — Apr 2018 [monthly]
Enrolling By Invitation PHASE4
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Guangzhou University of Traditional Chinese Medicine
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Guangzhou, China , Huizhou, China , Jiangmen, China , Jiekou, China , Lianjiang, China , Liaocheng, China , Licheng, China , Shenyang, China , Shouguang, China , Yangjiang, China and 1 more location